Skip to main content

Table 1 Baseline characteristics by treatment arm

From: Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial

Key characteristics

LSVT

NHS SLT

Deferred

 

(n = 30)

(n = 30)

(n = 29)

Demographic

 Age, mean (SD)

67 (8.4)

68 (10.3)

65 (7.5)

 Gender: n (%) male

23 (77)

23 (77)

23 (79)

Clinical history

 Years since diagnosed, mean (SD)

6.1 (3.7)

5.6 (4.2)

4.9 (3.9)

 Severity (H&Y stage) 2.5 and above, n (%)

10 (34)

13 (44)

6 (20)

 Number of PD medications, mean

2.1 (1)

1.9 (1)

1.6 (0.9)

Perception of speecha: n (%)

 Patient perceives speech/voice problems

23 (82)

23 (79)

 

 Speech affects social activities

18 (64)

14 (48)

 
  1. aCollected as part of initial SLT assessment, so only available for LSVT and NHS SLT groups